Kromek Group PLC

Kromek Group PLC

KMK · LSE · Technology / Scientific & Technical Instruments

5.30GBX-0.10 (-1.85%)

Price History

Full chart

Market Stats

Previous Close5.40
Open5.35
Day Range5.30 – 5.60
52-Week Range6.00 – 13.00
Volume344.80K
Market Cap39.97M
P/E (TTM)0.00
Forward P/E28.25
EPS0.00
Dividend Yield0.00%
Beta1.34
50-Day Avg7.51
200-Day Avg9.33

About

Kromek Group plc, together with its subsidiaries, develops, manufactures, and sells radiation detection components and bio-detection technology solutions for the advanced imaging, CBRN detection, and biological threat detection markets. It offers civil nuclear radiation detection products, which include gamma radiation and neutron detectors, high-specification, high-resolution devices, components, and software for nuclear detection problems, as well as offers a range of radiation detectors that use cadmium zinc telluride (CZT) or scintillator technology for gamma-ray and neutron detection. The company also provides advanced imaging products, including CZT gamma detectors for SPECT imaging, CZT bone mineral densitometry detectors, D-Matrix gamma ray imager, and photon-counting spectral CT systems. In addition, it offers products and components for the security and defence markets, including UAV radiation mapping drones, alpha beta probes, radiation detectors, gamma and neutron detectors, D5 RIID, backpack with radiation detection, static node, tactical deployment detector charging station, and vehicle mounted radiation detector, as well as a range of gamma spectroscopy software that enables specialized analysis of samples. Further, the company provides CZT imaging research development platforms, such as the DMatrix and the EV3500 scalable x-ray CZT linear array for laboratory and research imaging; and engages in the scientific research and development activities. It sells its products through distributors, OEMs, and direct sales. The company has operations in the United Kingdom, North America, Asia, Europe, and internationally. The company was founded in 2003 and is headquartered in Sedgefield, the United Kingdom.

Company Details

  • SectorTechnology
  • IndustryScientific & Technical Instruments
  • CEODr. Arnab Basu MBE
  • Employees166
  • HeadquartersNETPark, Sedgefield, United Kingdom, TS21 3FD, UK
  • Websitehttps://www.kromek.com

Leadership

  • Dr. Arnab Basu MBECEO & Executive Director · b. 1973
  • Mr. Albertus BeumerChief Commercial Officer, President of Advanced Imaging Division & Executive Director · b. 1964
  • Ms. Claire BurgessCFO, Company Secretary & Director · b. 1974

Financials

Income Statement

Currency: GBP2011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Revenue1.87M2.78M2.69M5.97M8.10M8.34M8.97M11.85M14.52M13.12M10.35M12.05M17.31M19.40M26.51M27.11M
Growth (%)-+48.88%-3.33%+121.91%+35.65%+2.97%+7.50%+32.08%+22.56%-9.62%-21.10%+16.45%+43.58%+12.10%+36.61%+2.30%
Cost of Revenue1.11M1.45M1.43M2.10M2.48M3.91M3.85M5.16M6.21M9.05M7.71M8.99M11.27M8.69M5.08M13.12M
Gross Profit757.06K1.33M1.26M3.87M5.63M4.43M5.12M6.68M8.31M4.07M2.65M3.07M6.04M10.71M21.43M14.00M
Gross Margin40.49%47.89%46.84%64.82%69.45%53.09%57.06%56.43%57.24%30.99%25.57%25.44%34.92%55.20%80.85%51.62%
Operating Expense4.15M4.39M5.16M8.30M8.75M8.51M8.87M9.03M9.21M9.46M8.48M8.78M12.09M12.09M16.73M11.09M
Operating Income-3.39M-3.05M-3.90M-4.43M-3.12M-4.08M-3.75M-2.34M-906.00K-5.39M-5.84M-5.71M-6.05M-1.38M4.70M2.90M
Operating Margin-181.35%-109.72%-144.98%-74.16%-38.54%-48.90%-41.86%-19.76%-6.24%-41.10%-56.39%-47.39%-34.95%-7.09%17.74%10.71%
EBITDA-2.77M-2.46M-773.22K-2.47M-1.65M-2.52M-1.57M386.00K1.93M-14.41M-1.74M-1.23M-1.25M2.93M6.16M7.00M
EBITDA Margin-148.17%-88.20%-28.73%-41.33%-20.36%-30.23%-17.51%3.26%13.32%-109.86%-16.80%-10.18%-7.24%15.09%23.23%25.82%
Net Income-2.78M-2.29M-641.55K-3.19M-2.15M-2.15M-3.08M-1.10M-633.00K-16.54M-5.35M-4.92M-6.10M-3.29M3.75M733.00K
Net Income Margin-148.81%-82.41%-23.84%-53.40%-26.49%-25.79%-34.39%-9.32%-4.36%-126.07%-51.71%-40.80%-35.24%-16.97%14.16%2.70%
R&D690.00K714.00K580.00K2.02M2.67M3.18M4.22M5.21M5.43M5.46M1.12M1.31M882.00K793.00K3.69M1.03K
R&D as % of Total Revenue36.90%25.65%21.55%33.82%32.95%38.10%47.06%44.03%37.42%41.59%10.78%10.85%5.10%4.09%13.91%0.00%
Interest Expense11.56K18.67K170.69K530.00K102.00K84.00K45.00K227.00K519.00K604.00K548.00K582.00K1.25M1.87M1.76M433.00K
Interest Expense % of Total Revenue0.62%0.67%6.34%8.87%1.26%1.01%0.50%1.92%3.58%4.60%5.29%4.83%7.19%9.66%6.66%1.60%

Balance Sheet

Currency: GBP2011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Total Assets7.42M8.91M15.17M22.08M22.52M29.11M49.95M47.18M75.74M64.66M70.16M67.42M63.88M70.19M65.87M70.27M
Total Liabilities1.57M2.51M7.14M4.34M6.32M4.45M7.74M6.92M15.41M19.59M20.10M19.99M22.35M20.84M13.69M15.84M
Total Equity5.85M6.40M8.03M17.74M16.20M24.65M42.21M40.26M60.34M45.07M50.05M47.44M41.52M49.35M52.18M54.43M
Cash443.38K477.15K308.94K6.56M1.18M3.86M20.34M9.49M20.62M9.44M15.60M5.08M1.10M466.00K1.70M4.16M
Total Debt-500.00K2.45M-1.03M9.00K3.00M3.00M9.66M9.77M12.86M11.00M13.38M12.29M4.05M9.36M
Net Debt-443.38K22.85K2.14M-6.56M-151.00K-3.85M-17.34M-6.49M-10.96M330.00K-2.74M5.92M12.28M11.82M2.35M5.19M

Cash Flow

Currency: GBP2011-04-302012-04-302013-04-302014-04-302015-04-302016-04-302017-04-302018-04-302019-04-302020-04-302021-04-302022-04-302023-04-302024-04-302025-04-302026-04-30
Operating Cash Flow-2.23M-1.89M-1.25M-2.22M-2.36M-2.85M-1.50M-4.61M-4.78M-126.00K-1.62M-3.84M-504.00K-2.80M15.90M3.00M
Investing Cash Flow-3.65M-1.27M-2.69M-1.80M-4.71M-3.58M-4.76M-5.58M-6.43M-11.21M-6.07M-6.45M-5.27M-5.00M-4.55M-4.94M
Financing Cash Flow1.90M3.20M3.73M10.50M1.78M9.19M22.81M-181.00K21.48M-544.00K14.13M-1.23M1.99M7.18M-9.19M4.56M
Capital Expenditure1.85M1.21M2.64M187.00K2.56M444.00K261.00K272.00K3.64M12.46M6.07M6.45M5.27M5.04M186.00K338.00K
Free Cash Flow-4.08M-3.10M-3.88M-2.40M-4.92M-3.29M-1.76M-4.88M-8.42M-12.59M-7.69M-10.29M-5.78M-7.84M15.71M2.67M
FCF to OCF182.67%163.90%311.70%108.43%208.34%115.61%117.40%105.90%176.28%9992.06%475.80%268.12%1146.23%279.94%98.83%88.75%

Earnings

Report DateAug 1, 2016Dec 7, 2016Jun 28, 2017Dec 19, 2017Jul 2, 2018Jan 14, 2019Jun 27, 2019Dec 11, 2019Oct 7, 2020Jan 13, 2021Jul 14, 2021Jan 18, 2022Jul 12, 2022Jan 31, 2023Jan 30, 2025Jul 31, 2025Oct 3, 2025Jan 20, 2026
EPS Estimate0.000.000.000.000.000.000.000.000.00-----0.000.000.000.00
EPS Actual0.00-0.01-0.010.000.00-0.010.00-0.01-0.04-0.01-0.01-0.01-0.01-0.01-0.010.010.010.01
Surprise------------------
Timing-Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-market-Pre-market----

Key Statistics & Ratios

Market Cap39.97M
Enterprise Value47.79M
Trailing P/E0.00
Forward P/E28.25
PEG Ratio0.00
Price / Sales1.47
Price / Book0.78
EPS0.00
Book Value0.087
Revenue (TTM)27.11M
Gross Profit (TTM)17.04M
EBITDA4.22M
Profit Margin2.70%
Operating Margin-2.42%
Return on Equity1.38%
Return on Assets2.67%
Shares Outstanding655.30M
Shares Float514.23M
Beta1.34
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Feb 15, 2021884:879
  • Feb 7, 2019726:725
  • Jul 31, 20151616:1599